These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2265739)

  • 1. [Blood cholesterol, diet and coronary risk: is the French population protected or threatened? Report of a consensus conference].
    Diabete Metab; 1990; 16(4):334-40; discussion 341-3. PubMed ID: 2265739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Consensus conference. Blood cholesterol, diet and coronary risk: is the French population protected or threatened? Paris, 17-18 November 1989].
    Rev Prat; 1990 Jan; 40(3):244-8. PubMed ID: 2406879
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypercholesterolemia in Belgium in 1996: an epidemiological viewpoint].
    Kornitzer M; De Bacquer D; De Backer G
    Rev Med Brux; 1997 Feb; 18(1):16-25. PubMed ID: 9132913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a worksite cholesterol education program over a 5-year period.
    Perovich SJ; Sandoval WM
    J Am Diet Assoc; 1995 May; 95(5):589-90. PubMed ID: 7722197
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors].
    Wahlberg G
    Lakartidningen; 2006 Jan 18-24; 103(3):131-4. PubMed ID: 16465756
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine.
    Mormando RM
    Geriatrics; 2000 Aug; 55(8):48-53; quiz 54. PubMed ID: 10953686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of subjects at high risk of coronary disease in a working population using a prediction model].
    Laurier D; Chau NP
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1569-75. PubMed ID: 8745990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triglycerides, HDL and coronary disease. Consensus conference: National Institutes of Health 1992].
    Ose L
    Tidsskr Nor Laegeforen; 1992 Sep; 112(21):2768-71. PubMed ID: 1412312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary heart disease risk factors among blood donors in northwest Ethiopia.
    Gebre-Yohannes A; Rahlenbeck SI
    East Afr Med J; 1998 Sep; 75(9):495-500. PubMed ID: 10493048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol: myth or reality?
    Thompson WG
    South Med J; 1990 Apr; 83(4):435-40. PubMed ID: 2181692
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum cholesterol trends among members of the Finnish parliament.
    Nikkari ST; Oksa P; Vattulainen K; Kohvakka A; Puska P; Roto P
    Prev Med; 1999 Mar; 28(3):260-3. PubMed ID: 10072744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 14. [The lowering of serum cholesterol in the prevention of coronary disease (part 1). The Canadian Study Group for Periodic Medical Examinations].
    Union Med Can; 1994 Apr; 123(4):249-58. PubMed ID: 8203048
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women.
    Thomas F; Bean K; Guize L; Quentzel S; Argyriadis P; Benetos A
    Eur Heart J; 2002 Apr; 23(7):528-35. PubMed ID: 11922642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cholesterol levels in Puerto Rican volunteer blood donors.
    Marcial MA; Fernández Carbia A
    Bol Asoc Med P R; 1989 Aug; 81(8):297-9. PubMed ID: 2765045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An affirmative view.
    Crouch MA
    J Fam Pract; 1988 Jun; 26(6):665-70. PubMed ID: 3379369
    [No Abstract]   [Full Text] [Related]  

  • 19. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.